行情

ANIK

ANIK

阿尼卡医疗
NASDAQ

实时行情|Nasdaq Last Sale

54.32
-0.17
-0.31%
盘后: 54.32 0 0.00% 16:00 09/18 EDT
开盘
54.85
昨收
54.49
最高
55.32
最低
53.59
成交量
15.86万
成交额
--
52周最高
58.93
52周最低
29.01
市值
7.49亿
市盈率(TTM)
26.46
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ANIK 新闻

  • 收盘:联储降息25个基点 美股收盘涨跌不一
  • 新浪美股.19分钟前
  • 观点综述:美联储“鹰派”降息导致股市走低
  • 新浪财经.47分钟前
  • 尾盘:道指转涨 纳指标普跌幅显著收窄
  • 新浪美股.54分钟前
  • 鲍威尔:美联储或将不得不恢复资产负债表增长
  • 新浪美股.1小时前

更多

所属板块

制药
+0.04%
制药与医学研究
-0.16%

热门股票

名称
价格
涨跌幅

ANIK 简况

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
展开

Webull提供Anika Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。